FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2155787419> ?p ?o ?g. }

• W2155787419 endingPage "2242" @default.
• W2155787419 startingPage "2236" @default.
• W2155787419 abstract "Hyperbilirubinaemia is a frequent complication of atazanavir-containing antiretroviral therapy and its severity is related to UDP-glucuronosyl transferase (UGT) 1A1*28 polymorphism. The aim of this study was to evaluate the safety and outcome of unboosted atazanavir-containing regimens based on the genetic constitution. Fifty-one HIV-1-infected patients on boosted atazanavir were prospectively enrolled in the study. Twenty-five patients with a UGT1A1*28 allele switched to 400 mg of unboosted atazanavir. At baseline, UGT1A1 heterozygous and homozygous patients had significantly higher bilirubin levels than wild-type (P = 0.012 and P < 0.001, respectively). After ritonavir removal, a reduction was observed in total bilirubin (from 4.09 to 1.82 mg/dL; P < 0.001), γ-glutamyl transpeptidase (P = 0.015), triglycerides (P = 0.03) and total cholesterol (P = 0.05). No significant changes in CD4 T cell count and no increases in viral load were observed 12 months after unboosting. Plasma drug monitoring after ritonavir removal revealed the presence of therapeutic atazanavir concentrations in all patients except one with poor therapy adherence. UGT1A1*28 is significantly related to hyperbilirubinaemia in HIV-1 patients receiving atazanavir. Genotyping before the initiation of antiretroviral therapy can reduce the emergence of severe hyperbilirubinaemia. Unboosted atazanavir-containing therapy is safe and efficacious in patients with an undetectable viral load with a UGT1A1*28 polymorphism, allowing the use of atazanavir in patients otherwise likely unable to receive it." @default.
• W2155787419 created "2016-06-24" @default.
• W2155787419 creator A5010848776 @default.
• W2155787419 creator A5014263659 @default.
• W2155787419 creator A5021206943 @default.
• W2155787419 creator A5026508012 @default.
• W2155787419 creator A5042128882 @default.
• W2155787419 creator A5044868040 @default.
• W2155787419 creator A5052366087 @default.
• W2155787419 creator A5063027312 @default.
• W2155787419 creator A5065476359 @default.
• W2155787419 creator A5082362012 @default.
• W2155787419 creator A5083803577 @default.
• W2155787419 creator A5085833746 @default.
• W2155787419 date "2012-06-02" @default.
• W2155787419 modified "2023-09-24" @default.
• W2155787419 title "Switching to unboosted atazanavir reduces bilirubin and triglycerides without compromising treatment efficacy in UGT1A1*28 polymorphism carriers" @default.
• W2155787419 cites W135351880 @default.
• W2155787419 cites W1520954009 @default.
• W2155787419 cites W1697799723 @default.
• W2155787419 cites W1980690358 @default.
• W2155787419 cites W1982947384 @default.
• W2155787419 cites W1984676832 @default.
• W2155787419 cites W1988633664 @default.
• W2155787419 cites W1991872551 @default.
• W2155787419 cites W1995727180 @default.
• W2155787419 cites W2014580004 @default.
• W2155787419 cites W2014999624 @default.
• W2155787419 cites W2015329000 @default.
• W2155787419 cites W2017011289 @default.
• W2155787419 cites W2057784811 @default.
• W2155787419 cites W2089720722 @default.
• W2155787419 cites W2095575152 @default.
• W2155787419 cites W2095708925 @default.
• W2155787419 cites W2107262592 @default.
• W2155787419 cites W2117312836 @default.
• W2155787419 cites W2120129846 @default.
• W2155787419 cites W2122443477 @default.
• W2155787419 cites W2123841216 @default.
• W2155787419 cites W2130445803 @default.
• W2155787419 cites W2145044292 @default.
• W2155787419 cites W2147235996 @default.
• W2155787419 cites W2148825772 @default.
• W2155787419 cites W2154345245 @default.
• W2155787419 cites W2159146649 @default.
• W2155787419 cites W2322536880 @default.
• W2155787419 doi "https://doi.org/10.1093/jac/dks175" @default.
• W2155787419 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22661571" @default.
• W2155787419 hasPublicationYear "2012" @default.
• W2155787419 type Work @default.
• W2155787419 sameAs 2155787419 @default.
• W2155787419 citedByCount "16" @default.
• W2155787419 countsByYear W21557874192012 @default.
• W2155787419 countsByYear W21557874192013 @default.
• W2155787419 countsByYear W21557874192014 @default.
• W2155787419 countsByYear W21557874192015 @default.
• W2155787419 countsByYear W21557874192016 @default.
• W2155787419 countsByYear W21557874192017 @default.
• W2155787419 countsByYear W21557874192018 @default.
• W2155787419 countsByYear W21557874192019 @default.
• W2155787419 crossrefType "journal-article" @default.
• W2155787419 hasAuthorship W2155787419A5010848776 @default.
• W2155787419 hasAuthorship W2155787419A5014263659 @default.
• W2155787419 hasAuthorship W2155787419A5021206943 @default.
• W2155787419 hasAuthorship W2155787419A5026508012 @default.
• W2155787419 hasAuthorship W2155787419A5042128882 @default.
• W2155787419 hasAuthorship W2155787419A5044868040 @default.
• W2155787419 hasAuthorship W2155787419A5052366087 @default.
• W2155787419 hasAuthorship W2155787419A5063027312 @default.
• W2155787419 hasAuthorship W2155787419A5065476359 @default.
• W2155787419 hasAuthorship W2155787419A5082362012 @default.
• W2155787419 hasAuthorship W2155787419A5083803577 @default.
• W2155787419 hasAuthorship W2155787419A5085833746 @default.
• W2155787419 hasBestOaLocation W21557874191 @default.
• W2155787419 hasConcept C104317684 @default.
• W2155787419 hasConcept C126322002 @default.
• W2155787419 hasConcept C135763542 @default.
• W2155787419 hasConcept C142462285 @default.
• W2155787419 hasConcept C185592680 @default.
• W2155787419 hasConcept C203014093 @default.
• W2155787419 hasConcept C2777513400 @default.
• W2155787419 hasConcept C2778414717 @default.
• W2155787419 hasConcept C2779298103 @default.
• W2155787419 hasConcept C2993143319 @default.
• W2155787419 hasConcept C3013748606 @default.
• W2155787419 hasConcept C31467283 @default.
• W2155787419 hasConcept C55493867 @default.
• W2155787419 hasConcept C71924100 @default.
• W2155787419 hasConcept C90924648 @default.
• W2155787419 hasConcept C98274493 @default.
• W2155787419 hasConceptScore W2155787419C104317684 @default.
• W2155787419 hasConceptScore W2155787419C126322002 @default.
• W2155787419 hasConceptScore W2155787419C135763542 @default.
• W2155787419 hasConceptScore W2155787419C142462285 @default.
• W2155787419 hasConceptScore W2155787419C185592680 @default.
• W2155787419 hasConceptScore W2155787419C203014093 @default.
• W2155787419 hasConceptScore W2155787419C2777513400 @default.
• W2155787419 hasConceptScore W2155787419C2778414717 @default.

• next